Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2016 (2016), Article ID 1578235, 8 pages
http://dx.doi.org/10.1155/2016/1578235
Research Article

Impact of Oxidative Stress in Premature Aging and Iron Overload in Hemodialysis Patients

1Unidad de Investigación en Epidemiología Clínica, Servicio de Hemodiálisis, Unidad Médica de Alta Especialidad (UMAE) No. 1 Bajío, Instituto Mexicano del Seguro Social (IMSS), León, GTO, Mexico
2Departamento de Investigaciones Médicas, Universidad de Guanajuato, León, GTO, Mexico
3Unidad de Investigación Médica en Enfermedades Oncológicas, CMN, SXXI, IMSS, 06720 Ciudad de México, Mexico

Received 1 April 2016; Revised 15 July 2016; Accepted 23 August 2016

Academic Editor: Claudio Cabello-Verrugio

Copyright © 2016 Blanca Murillo-Ortiz et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. Weiss and L. T. Goodnough, “Anemia of chronic disease,” The New England Journal of Medicine, vol. 352, no. 10, pp. 1011–1023, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. S. M. Lynch and B. Frei, “Mechanisms of metal ion-dependent oxidation of human low density lipoprotein,” Journal of Nutrition, vol. 126, no. 4, 1996. View at Google Scholar · View at Scopus
  3. E. Wieland, S. Parthasarathy, and D. Steinberg, “Peroxidase-dependent metal-independent oxidation of low density lipoprotein in vitro: a model for in vivo oxidation?” Proceedings of the National Academy of Sciences of the United States of America, vol. 90, no. 13, pp. 5929–5933, 1993. View at Publisher · View at Google Scholar · View at Scopus
  4. S. M. King, C. M. Donangelo, M. D. Knutson et al., “Daily supplementation with iron increases lipid peroxidation in young women with low iron stores,” Experimental Biology and Medicine, vol. 233, no. 6, pp. 701–707, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. X. Chai, D. Li, X. Cao et al., “ROS-mediated iron overload injures the hematopoiesis of bone marrow by damaging hematopoietic stem/progenitor cells in mice,” Scientific Reports, vol. 5, Article ID 10181, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. G. Y. Oudit, M. G. Trivieri, N. Khaper et al., “Taurine supplementation reduces oxidative stress and improves cardiovascular function in an iron-overload murine model,” Circulation, vol. 109, no. 15, pp. 1877–1885, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. S. K. Das, W. Wang, P. Zhabyeyev et al., “Iron-overload injury and cardiomyopathy in acquired and genetic models is attenuated by resveratrol therapy,” Scientific Reports, vol. 5, article 18132, 2015. View at Publisher · View at Google Scholar · View at Scopus
  8. F. A. Badria, A. S. Ibrahim, A. F. Badria, and A. A. Elmarakby, “Curcumin attenuates iron accumulation and oxidative stress in the liver and spleen of chronic iron-overloaded rats,” PLoS ONE, vol. 10, no. 7, Article ID e0134156, 2015. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Sripetchwandee, N. Pipatpiboon, N. Chattipakorn, and S. Chattipakorn, “Combined therapy of iron chelator and antioxidant completely restores brain dysfunction induced by iron toxicity,” PLoS ONE, vol. 9, no. 1, Article ID e85115, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. E. Skrzydlewska, S. Sulkowski, M. Koda, B. Zalewski, L. Kanczuga-Koda, and M. Sulkowska, “Lipid peroxidation and antioxidant status in colorectal cancer,” World Journal of Gastroenterology, vol. 11, no. 3, pp. 403–406, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Benetos, K. Okuda, M. Lajemi et al., “Telomere length as an indicator of biological aging—the gender effect and relation with pulse pressure and pulse wave velocity,” Hypertension, vol. 37, no. 2, pp. 381–385, 2001. View at Publisher · View at Google Scholar · View at Scopus
  12. M. C. Boxall, T. H. J. Goodship, A. L. Brown, M. C. Ward, and T. von Zglinicki, “Telomere shortening and haemodialysis,” Blood Purification, vol. 24, no. 2, pp. 185–189, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. E. Jeanclos, N. J. Schork, K. O. Kyvik, M. Kimura, J. H. Skurnick, and A. Aviv, “Telomere length inversely correlates with pulse pressure and is highly familial,” Hypertension, vol. 36, no. 2, pp. 195–200, 2000. View at Publisher · View at Google Scholar · View at Scopus
  14. B. Murillo-Ortiz, F. Albarrán-Tamayo, D. Arenas-Aranda et al., “Telomere length and type 2 diabetes in males, a premature aging syndrome,” Aging Male, vol. 15, no. 1, pp. 54–58, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. L. P. Wills and R. G. Schnellmann, “Telomeres and telomerase in renal health,” Journal of the American Society of Nephrology, vol. 22, no. 1, pp. 39–41, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. J. L. Sullivan, “Iron and the sex difference in heart disease risk,” The Lancet, vol. 317, no. 8233, pp. 1293–1294, 1981. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Kiechl, J. Willeit, G. Egger, W. Poewe, and F. Oberhollenzer, “Body iron stores and the risk of carotid atherosclerosis: prospective results from the bruneck study,” Circulation, vol. 96, no. 10, pp. 3300–3307, 1997. View at Publisher · View at Google Scholar · View at Scopus
  18. K. Klipstein-Grobusch, J. F. Koster, D. E. Grobbee et al., “Serum ferritin and risk of myocardial infarction in the elderly: the Rotterdam Study,” American Journal of Clinical Nutrition, vol. 69, no. 6, pp. 1231–1236, 1999. View at Google Scholar · View at Scopus
  19. E. Senol, A. Ersoy, S. Erdinc, E. Sarandol, and M. Yurtkuran, “Oxidative stress and ferritin levels in haemodialysis patients,” Nephrology Dialysis Transplantation, vol. 23, no. 2, pp. 665–672, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Laddha, V. Sachdeva, P. M. Diggikar, P. K. Satpathy, and A. L. Kakrani, “Echocardiographic assessment of cardiac dysfunction in patients of end stage renal disease on haemodialysis,” Journal of Association of Physicians of India, vol. 62, pp. 28–33, 2014. View at Google Scholar · View at Scopus
  21. L. S. M. Wong, P. van der Harst, R. A. de Boer et al., “Renal dysfunction is associated with shorter telomere length in heart failure,” Clinical Research in Cardiology, vol. 98, no. 10, pp. 629–634, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. J. Kletzmayr and W. H. Hörl, “Iron overload and cardiovascular complications in dialysis patients,” Nephrology Dialysis Transplantation, vol. 17, supplement 2, pp. 25–29, 2002. View at Google Scholar · View at Scopus
  23. I. S. Vari, B. Balkau, A. Kettaneh et al., “Ferritin and transferrin are associated with metabolic syndrome abnormalities and their change over time in a general population: data from an Epidemiological Study on the Insulin Resistance syndrome (DESIR),” Diabetes Care, vol. 30, no. 7, pp. 1795–1801, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. K. A. Schwartz, Z. Li, D. E. Schwartz, T. G. Cooper, and W. Emmett Braselton, “Earliest cardiac toxicity induced by iron overload selectively inhibits electrical conduction,” Journal of Applied Physiology, vol. 93, no. 2, pp. 746–751, 2002. View at Publisher · View at Google Scholar · View at Scopus
  25. A. G. Mainous III and V. A. Díaz, “Relation of serum ferritin level to cardiovascular fitness among young men,” The American Journal of Cardiology, vol. 103, no. 1, pp. 115–118, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. B. de Valk and J. J. M. Marx, “Iron, atherosclerosis, and ischemic heart disease,” Archives of Internal Medicine, vol. 159, no. 14, pp. 1542–1548, 1999. View at Publisher · View at Google Scholar · View at Scopus
  27. R. M. Cawthon, “Telomere measurement by quantitative PCR,” Nucleic Acids Research, vol. 30, no. 10, article e47, 2002. View at Publisher · View at Google Scholar · View at Scopus
  28. E. Franco-Robles, A. Campos-Cervantes, B. O. Murillo-Ortiz et al., “Effects of curcumin on brain-derived neurotrophic factor levels and oxidative damage in obesity and diabetes,” Applied Physiology, Nutrition and Metabolism, vol. 39, no. 2, pp. 211–218, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. B. Descamps-Latscha, P. Jungers, and V. Witko-Sarsat, “Immune system dysregulation in uremia: role of oxidative stress,” Blood Purification, vol. 20, no. 5, pp. 481–484, 2002. View at Publisher · View at Google Scholar · View at Scopus
  30. S. Sela, R. Shurtz-Swirski, M. Cohen-Mazor et al., “Primed peripheral polymorphonuclear leukocyte: a culprit underlying chronic low-grade inflammation and systemic oxidative stress in chronic kidney disease,” Journal of the American Society of Nephrology, vol. 16, no. 8, pp. 2431–2438, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. P. M. Honoré, R. Jacobs, W. Boer, and O. Joannes-Boyau, “Sepsis and AKI: more complex than just a simple question of chicken and egg,” Intensive Care Medicine, vol. 37, no. 2, pp. 186–189, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. T. Von Zglinicki, “Oxidative stress shortens telomeres,” Trends in Biochemical Sciences, vol. 27, no. 7, pp. 339–344, 2002. View at Publisher · View at Google Scholar · View at Scopus
  33. J. Galle, “Oxidative stress in chronic renal failure,” Nephrology Dialysis Transplantation, vol. 16, no. 11, pp. 2135–2137, 2001. View at Publisher · View at Google Scholar · View at Scopus
  34. N. J. Samani, R. Boultby, R. Butler, J. R. Thompson, and A. H. Goodall, “Telomere shortening in atherosclerosis,” The Lancet, vol. 358, no. 9280, pp. 472–473, 2001. View at Publisher · View at Google Scholar · View at Scopus
  35. A. Levin, C. R. Thompson, J. Ethier et al., “Left ventricular mass index increase in early renal disease: impact of decline in hemoglobin,” American Journal of Kidney Diseases, vol. 34, no. 1, pp. 125–134, 1999. View at Publisher · View at Google Scholar · View at Scopus
  36. R. S. Vasan, S. Demissie, M. Kimura et al., “Association of leukocyte telomere length with echocardiographic left ventricular mass: the Framingham heart study,” Circulation, vol. 120, no. 13, pp. 1195–1202, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. M. M. Sung, S. K. Das, J. Levasseur et al., “Resveratrol treatment of mice with pressure-overload-induced heart failure improves diastolic function and cardiac energy metabolism,” Circulation: Heart Failure, vol. 8, no. 1, pp. 128–137, 2015. View at Publisher · View at Google Scholar · View at Scopus
  38. B. Franczyk-Skóra, A. Gluba, R. Olszewski, M. Banach, and J. Rysz, “Heart function disturbances in chronic kidney disease—echocardiographic indices,” Archives of Medical Science, vol. 10, no. 6, pp. 1109–1116, 2014. View at Publisher · View at Google Scholar · View at Scopus
  39. G. A. Stewart, P. B. Mark, N. Johnston et al., “Determinants of hypertension and left ventricular function in end stage renal failure: a pilot study using cardiovascular magnetic resonance imaging,” Clinical Physiology and Functional Imaging, vol. 24, no. 6, pp. 387–393, 2004. View at Publisher · View at Google Scholar · View at Scopus
  40. R. B. Devereux, D. R. Alonso, E. M. Lutas et al., “Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings,” The American Journal of Cardiology, vol. 57, no. 6, pp. 450–458, 1986. View at Publisher · View at Google Scholar · View at Scopus
  41. C. J. Murphy and G. Y. Oudit, “Iron-overload cardiomyopathy: pathophysiology, diagnosis, and treatment,” Journal of Cardiac Failure, vol. 16, no. 11, pp. 888–900, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. D. J. Pennell, J. E. Udelson, A. E. Arai et al., “Cardiovascular function and treatment in beta-thalassemia major: a consensus statement from the American Heart Association,” Circulation, vol. 128, no. 3, pp. 281–308, 2013. View at Publisher · View at Google Scholar
  43. N. F. Olivieri, D. G. Nathan, J. H. Macmillan et al., “Survival in medically treated patients with homozygous β-thalassemia,” The New England Journal of Medicine, vol. 331, no. 9, pp. 574–578, 1994. View at Publisher · View at Google Scholar · View at Scopus
  44. G. M. Brittenham, P. M. Griffith, A. W. Nienhuis et al., “Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major,” The New England Journal of Medicine, vol. 331, no. 9, pp. 567–573, 1994. View at Publisher · View at Google Scholar · View at Scopus
  45. F. W. Huang, J. L. Pinkus, G. S. Pinkus, M. D. Fleming, and N. C. Andrews, “A mouse model of juvenile hemochromatosis,” The Journal of Clinical Investigation, vol. 115, no. 8, pp. 2187–2191, 2005. View at Publisher · View at Google Scholar · View at Scopus
  46. J. C. Wood, M. Otto-Duessel, M. Aguilar et al., “Cardiac iron determines cardiac T2, T2, and T1 in the gerbil model of iron cardiomyopathy,” Circulation, vol. 112, no. 4, pp. 535–543, 2005. View at Publisher · View at Google Scholar · View at Scopus
  47. H. Ghoti, E. A. Rachmilewitz, R. Simon-Lopez et al., “Evidence for tissue iron overload in long-term hemodialysis patients and the impact of withdrawing parenteral iron,” European Journal of Haematology, vol. 89, no. 1, pp. 87–93, 2012. View at Publisher · View at Google Scholar · View at Scopus
  48. A. E. Gaweda, Y. Z. Ginzburg, Y. Chait, M. J. Germain, G. R. Aronoff, and E. Rachmilewitz, “Iron dosing in kidney disease: inconsistency of evidence and clinical practice,” Nephrology Dialysis Transplantation, vol. 30, no. 2, pp. 187–196, 2015. View at Publisher · View at Google Scholar · View at Scopus
  49. I. C. Macdougall, A. J. Bircher, K. Eckardt et al., “Iron management in chronic kidney disease: conclusions from a ‘kidney disease: improving global outcomes’ (KDIGO) Controversies Conference,” Kidney International, vol. 89, no. 1, pp. 28–39, 2016. View at Publisher · View at Google Scholar